← Back to patent-cliff list
CAS 37709-42-5
1-Methyl-2-oxocyclohexane-1-carbaldehyde
Codes: (V)101438-76-a
Application context (from source-drug indications)
Breast cancerPaclitaxel/Encequidar mesylateAdenocarcinomaPaclitaxel/Encequidar mesylateAngiosarcomaPaclitaxel/Encequidar mesylateSolid tumourPaclitaxel/Encequidar mesylatePancreatic cancerPaclitaxelNon-small cell lung cancerPaclitaxelHodgkin's diseasePaclitaxelSeminomaPaclitaxelOvarian cancerPaclitaxelBreast cancerPaclitaxel
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Paclitaxel/Encequidar mesylate | Tier C — Watch / trade | - |
| Paclitaxel | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
5-Hexenyl bromide→1-Phenyltetrazoline-5-thione→5-[(Hex-5-en-1-yl)sulfanyl]-1-phenyl-1H-tetrazole→5-(Hex-5-ene-1-sulfonyl)-1-phenyl-1H-tetrazole→1-Methyl-2-oxocyclohexane-1-carbaldehyde→2-Methyl-2-(octa-1,7-dien-1-yl)cyclohexan-1-one→2,4,6-Triisopropylbenzenesulfonohydrazide→N'-[2-Methyl-2-(octa-1,7-dien-1-yl)cyclohexylidene]-2,4,6-tri(propan-2-yl)benzene-1-sulfonohydrazide
5-Hexenyl bromide→1-Phenyltetrazoline-5-thione→5-[(Hex-5-en-1-yl)sulfanyl]-1-phenyl-1H-tetrazole→5-(Hex-5-ene-1-sulfonyl)-1-phenyl-1H-tetrazole→1-Methyl-2-oxocyclohexane-1-carbaldehyde→2-Methyl-2-(octa-1,7-dien-1-yl)cyclohexan-1-one→2,4,6-Triisopropylbenzenesulfonohydrazide→N'-[2-Methyl-2-(octa-1,7-dien-1-yl)cyclohexylidene]-2,4,6-tri(propan-2-yl)benzene-1-sulfonohydrazide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.